Skip to main content

Nitroprusside

  • Chapter
  • 80 Accesses

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 72))

Abstract

Nitroprusside, a direct-acting balanced vasodilator affecting both arteries and veins, is effective in short-term management of patients with congestive heart failure, acute myocardial infarction or malignant hypertension, and patients undergoing surgery of the heart or the aorta. It is effective only by intravenous administration and therefore can be used only in hospitalized patients. It is effective in all age groups, from infants to geriatric patients. Its mechanism of action is not known.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Miller RR, et al: Clinical use of sodium nitroprusside in chronic ischemic heart disease. Circulation 51:328, 1975.

    PubMed  CAS  Google Scholar 

  2. Chatterjee K, et al: Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48:1183, 1973.

    PubMed  CAS  Google Scholar 

  3. Franciosa JA, Silverstein SR: Hemodynamic effects of nitroprusside and furosemide in left ventricular failure. Clin Pharmacol Ther 32:62, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Packer M, et al: Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy. Circulation 64:506, 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Packer M, et al: Sustained effectiveness of minoxidil in heart failure after development of tolerance to other vasodilator drugs. Am J Cardiol 48:375, 1981.

    Article  PubMed  CAS  Google Scholar 

  6. Shah PK, et al: Effects of nitroprusside-induced reduction of elevated preload and afterload on global and regional ventricular function in acute myocardial infarction. Am Heart J 105:531, 1983.

    Article  PubMed  CAS  Google Scholar 

  7. Hockings BEF, et al: Randomized controlled trial of vasodilator therapy after myocardial infarction. Am J Cardiol 48:345, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Shenaq SA, et al: Use of nitroprusside during surgery for thoracoabdominal aortic aneurysm. Circulation [Suppl 1] 70:1–7, 1984.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Schneeweiss, A., Schettler, G. (1987). Nitroprusside. In: Cardiovascular Drug Therapy in the Elderly. Developments in Cardiovascular Medicine, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2063-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2063-0_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9225-8

  • Online ISBN: 978-1-4613-2063-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics